CADL•benzinga•
Canaccord Genuity Maintains Buy on Candel Therapeutics, Raises Price Target to $25
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 26, 2025 by benzinga